180 related articles for article (PubMed ID: 25577223)
1. Charlson comorbidity index: an additional prognostic parameter for preoperative glioblastoma patient stratification.
Ening G; Osterheld F; Capper D; Schmieder K; Brenke C
J Cancer Res Clin Oncol; 2015 Jun; 141(6):1131-7. PubMed ID: 25577223
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for glioblastoma therapy associated complications.
Ening G; Osterheld F; Capper D; Schmieder K; Brenke C
Clin Neurol Neurosurg; 2015 Jul; 134():55-9. PubMed ID: 25942630
[TBL] [Abstract][Full Text] [Related]
3. Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles.
Barbagallo GM; Paratore S; Caltabiano R; Palmucci S; Parra HS; Privitera G; Motta F; Lanzafame S; Scaglione G; Longo A; Albanese V; Certo F
Neurosurg Focus; 2014 Dec; 37(6):E4. PubMed ID: 25434389
[TBL] [Abstract][Full Text] [Related]
4. Extent of tumor removal and molecular markers in cerebral glioblastoma: a combined prognostic factors study in a surgical series of 105 patients.
Salvati M; Pichierri A; Piccirilli M; Floriana Brunetto GM; D'Elia A; Artizzu S; Santoro F; Arcella A; Giangaspero F; Frati A; Simione L; Santoro A
J Neurosurg; 2012 Aug; 117(2):204-11. PubMed ID: 22655594
[TBL] [Abstract][Full Text] [Related]
5. Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma Network.
Weller M; Felsberg J; Hartmann C; Berger H; Steinbach JP; Schramm J; Westphal M; Schackert G; Simon M; Tonn JC; Heese O; Krex D; Nikkhah G; Pietsch T; Wiestler O; Reifenberger G; von Deimling A; Loeffler M
J Clin Oncol; 2009 Dec; 27(34):5743-50. PubMed ID: 19805672
[TBL] [Abstract][Full Text] [Related]
6. Increased xCT expression correlates with tumor invasion and outcome in patients with glioblastomas.
Takeuchi S; Wada K; Toyooka T; Shinomiya N; Shimazaki H; Nakanishi K; Nagatani K; Otani N; Osada H; Uozumi Y; Matsuo H; Nawashiro H
Neurosurgery; 2013 Jan; 72(1):33-41; discussion 41. PubMed ID: 23096413
[TBL] [Abstract][Full Text] [Related]
7. Limited role for extended maintenance temozolomide for newly diagnosed glioblastoma.
Gramatzki D; Kickingereder P; Hentschel B; Felsberg J; Herrlinger U; Schackert G; Tonn JC; Westphal M; Sabel M; Schlegel U; Wick W; Pietsch T; Reifenberger G; Loeffler M; Bendszus M; Weller M
Neurology; 2017 Apr; 88(15):1422-1430. PubMed ID: 28298550
[TBL] [Abstract][Full Text] [Related]
8. Craniotomy for recurrent glioblastoma: Is it justified? A comparative cohort study with outcomes over 10 years.
Mukherjee S; Wood J; Liaquat I; Stapleton SR; Martin AJ
Clin Neurol Neurosurg; 2020 Jan; 188():105568. PubMed ID: 31739155
[TBL] [Abstract][Full Text] [Related]
9. A five-miRNA signature with prognostic and predictive value for MGMT promoter-methylated glioblastoma patients.
Cheng W; Ren X; Cai J; Zhang C; Li M; Wang K; Liu Y; Han S; Wu A
Oncotarget; 2015 Oct; 6(30):29285-95. PubMed ID: 26320189
[TBL] [Abstract][Full Text] [Related]
10. Does the expression of glial fibrillary acid protein (GFAP) stain in glioblastoma tissue have a prognostic impact on survival?
Ahmadipour Y; Gembruch O; Pierscianek D; Sure U; Jabbarli R
Neurochirurgie; 2020 Jun; 66(3):150-154. PubMed ID: 32278699
[TBL] [Abstract][Full Text] [Related]
11. Temozolomide in elderly patients with newly diagnosed glioblastoma and poor performance status: an ANOCEF phase II trial.
Gállego Pérez-Larraya J; Ducray F; Chinot O; Catry-Thomas I; Taillandier L; Guillamo JS; Campello C; Monjour A; Cartalat-Carel S; Barrie M; Huchet A; Beauchesne P; Matta M; Mokhtari K; Tanguy ML; Honnorat J; Delattre JY
J Clin Oncol; 2011 Aug; 29(22):3050-5. PubMed ID: 21709196
[TBL] [Abstract][Full Text] [Related]
12. IDH mutation and MGMT promoter methylation are associated with the pseudoprogression and improved prognosis of glioblastoma multiforme patients who have undergone concurrent and adjuvant temozolomide-based chemoradiotherapy.
Li H; Li J; Cheng G; Zhang J; Li X
Clin Neurol Neurosurg; 2016 Dec; 151():31-36. PubMed ID: 27764705
[TBL] [Abstract][Full Text] [Related]
13. Repeat-surgery at Glioblastoma recurrence, when and why to operate?
Ening G; Huynh MT; Schmieder K; Brenke C
Clin Neurol Neurosurg; 2015 Sep; 136():89-94. PubMed ID: 26092644
[TBL] [Abstract][Full Text] [Related]
14. Early postoperative tumor progression predicts clinical outcome in glioblastoma-implication for clinical trials.
Merkel A; Soeldner D; Wendl C; Urkan D; Kuramatsu JB; Seliger C; Proescholdt M; Eyupoglu IY; Hau P; Uhl M
J Neurooncol; 2017 Apr; 132(2):249-254. PubMed ID: 28101701
[TBL] [Abstract][Full Text] [Related]
15. [Clinical, immunohistochemical, and molecular genetic prognostic factors in adult patients with glioblastoma].
Lobanova NV; Shishkina LV; Ryzhova MV; Kobyakov GL; Sycheva RV; Burov SA; Lukyanov AV; Omarova ZR
Arkh Patol; 2016; 78(4):10-19. PubMed ID: 27600777
[TBL] [Abstract][Full Text] [Related]
16. Isocitrate dehydrogenase 1 Gene Mutation Is Associated with Prognosis in Clinical Low-Grade Gliomas.
Li MY; Wang YY; Cai JQ; Zhang CB; Wang KY; Cheng W; Liu YW; Zhang W; Jiang T
PLoS One; 2015; 10(6):e0130872. PubMed ID: 26115094
[TBL] [Abstract][Full Text] [Related]
17. MGMT gene promoter methylation as a potent prognostic factor in glioblastoma treated with temozolomide-based chemoradiotherapy: a single-institution study.
Kim YS; Kim SH; Cho J; Kim JW; Chang JH; Kim DS; Lee KS; Suh CO
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):661-7. PubMed ID: 22414280
[TBL] [Abstract][Full Text] [Related]
18. The relative value of postoperative versus preoperative Karnofsky Performance Scale scores as a predictor of survival after surgical resection of glioblastoma multiforme.
Chambless LB; Kistka HM; Parker SL; Hassam-Malani L; McGirt MJ; Thompson RC
J Neurooncol; 2015 Jan; 121(2):359-64. PubMed ID: 25344883
[TBL] [Abstract][Full Text] [Related]
19. Pathological findings and prognostic factors in recurrent glioblastomas.
Okita Y; Narita Y; Miyakita Y; Ohno M; Fukushima S; Kayama T; Shibui S
Brain Tumor Pathol; 2012 Oct; 29(4):192-200. PubMed ID: 22331317
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcome of gliosarcoma compared with glioblastoma multiforme: a clinical study in Chinese patients.
Zhang G; Huang S; Zhang J; Wu Z; Lin S; Wang Y
J Neurooncol; 2016 Apr; 127(2):355-62. PubMed ID: 26725096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
